Should we be screening for thyroid dysfunction in patients with type 2 diabetes mellitus?

Br J Gen Pract. 2018 Feb;68(667):94-95. doi: 10.3399/bjgp18X694793.
No abstract available

MeSH terms

  • Cost-Benefit Analysis
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / physiopathology*
  • General Practice*
  • Guidelines as Topic
  • Humans
  • Mass Screening*
  • Prevalence
  • Thyroid Diseases / blood
  • Thyroid Diseases / diagnosis*
  • Thyroid Diseases / physiopathology